Abstract
Objective: To define the test place of T-Spot.TB gamma-interferon release in the algorithm of diagnosing and diagnostics of different onsets of tuberculosis infection among children and adloscents. Methods : T-Spot.TB test results among children under 17 years old were examined as an alternative screening method (n=4096), in VI dispensary observation group (n=645) and among patients suffering tuberculosis (n=15). Results : T-Spot.TB effectiveness as a screening test was 2.8 %. Matching this test’s results and the skin test with tuberculosis recombinant allergen (TRA) in a year of observation demonstrated negative result in 90.7 % of cases in the event of uncertain or weakly positive TRA reaction. Conclusions: Child population tuberculosis screening under 7 years old should be held using Mantoux reaction, but from 8 to 17 years old – using TRA test. Gamma-interferon T-Spot. TB test can be held on a contract basis as an alternative child screening method if the legal representative refused to make recommended skin tests. Immunosuppression of various origins, allergies and obesity can be considered as medical indicators to prescribe this test for children and adolescents.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
